Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

An in vitro model of a hypertrophic tissue engineered myocardium

EF 2011-12

Résumé
Cardiovascular disease is the leading cause of death globally and is predicted to continue being the leading cause of death until at least 2030. While there have been many improvements to help relieve acute complications of cardiovascular disease there is no permanent solution. This means that people can survive heart attacks but, the heart will not repair itself leading to the continuous decline in patient health. Consequently, the majority of patients suffering from chronic cardiovascular disease, such as heart failure, is increasing to epidemic levels and is becoming a serious burden on the medical system. Instead of trying to find ways to treat patients with new therapies for after a heart attack, it is better to find ways to diagnose patients to determine whether or not they have a cardiovascular disease. As a result, doctors will be able to treat the heart problem before it escalates and alleviate costly procedures for patients that have suffered a heart attack and the continuous care that accompanies these patients. My research aims to uncover how the heart goes from a healthy state to a diseased state. To do this I will be creating artificial heart tissue from human embryonic stem cells that have been differentiated into cardiomyocytes, the main cell that makes up the heart. These engineered heart tissues will be subjected to various hormones to induce a diseased state. Various techniques will be used to then analyze these diseased engineered heart tissues to quantify the degradation of the tissue. By understanding why and how the heart becomes diseased, better detection methods can be created to help improve the diagnoses of patients in hospitals. This will lead to a reduced burden on the medical system as this research aims to create a preventative solution to cardiovascular disease rather than a therapy created in response to cardiovascular disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
255028
Name
Miklas Jason W
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
An in vitro model of a hypertrophic tissue engineered myocardium
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiac Hypertrophy; Cardiac Tissue Engineering; Cardiomyocytes; Confocal Microscopy; Human Embryonic Stem Cells; Real Time Polymerase Chain Reaction; Regenerative Medicine; Transmission Electron Microscopy
Abstract
Cardiovascular disease is the leading cause of death globally and is predicted to continue being the leading cause of death until at least 2030. While there have been many improvements to help relieve acute complications of cardiovascular disease there is no permanent solution. This means that people can survive heart attacks but, the heart will not repair itself leading to the continuous decline in patient health. Consequently, the majority of patients suffering from chronic cardiovascular disease, such as heart failure, is increasing to epidemic levels and is becoming a serious burden on the medical system. Instead of trying to find ways to treat patients with new therapies for after a heart attack, it is better to find ways to diagnose patients to determine whether or not they have a cardiovascular disease. As a result, doctors will be able to treat the heart problem before it escalates and alleviate costly procedures for patients that have suffered a heart attack and the continuous care that accompanies these patients. My research aims to uncover how the heart goes from a healthy state to a diseased state. To do this I will be creating artificial heart tissue from human embryonic stem cells that have been differentiated into cardiomyocytes, the main cell that makes up the heart. These engineered heart tissues will be subjected to various hormones to induce a diseased state. Various techniques will be used to then analyze these diseased engineered heart tissues to quantify the degradation of the tissue. By understanding why and how the heart becomes diseased, better detection methods can be created to help improve the diagnoses of patients in hospitals. This will lead to a reduced burden on the medical system as this research aims to create a preventative solution to cardiovascular disease rather than a therapy created in response to cardiovascular disease.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Miklas, Jason W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~